- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00715312
Effect of Oleic Acid on Inflammation Markers and Blood Lipid Metabolites: A Randomised, Double-Blind, Crossover Study
Effect of Oleic Acid on Inflammation Markers and Blood Lipid Metabolites: A Randomised, Double-Blind, Crossover Study.
Rationale: The effect of positional distribution of dietary fatty acids on markers of inflammation and blood lipids metabolites on diets containing fatty acids such as oleic acid that are associated with reduced risk of cardiovascular disease is not widely studied.
Hypothesis: There would be difference detected in the concentrations of markers of inflammation and blood lipid metabolites in human volunteers fed controlled diets.
Study design: A randomized, double-blind, crossover clinical trial that involves 41 healthy volunteers. The volunteers will be selected based on inclusion and exclusion criteria. They will consume controlled diets for 5 weeks that provides 15% of energy from protein, 30% of energy from fat, and 55% of energy from carbohydrates. Volunteers will be assigned to each test diets which is cooked with novel olein, palm stearin or partially hydrogenated soybean oil in random order until all three diets has consumed by each person.
Main study parameters: LDL-cholesterol
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Selangor
-
Kajang, Selangor, Malaysia, 50720
- Malaysia Palm Oil Board
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy and free from any disease and absence of family history for arteriosclerosis or hypertension
- Not on any medication or supplements or weight loss program
- Non smokers and alcoholics
Exclusion Criteria:
- Having some health-related problems e.g fever, flu, allergy, chronic diseases
- On some treatment or medication
- Smokers and alcoholics
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: A
|
A total of 70g of test oil is incorporated into cooked meal which accounts for 30-35% of calorie intake
A total of 70g of test oil is incorporated into cooked meal which provides 30-35% of calorie
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
LDL-cholesterol
Time Frame: 5 weeks
|
5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
C-reactive protein
Time Frame: 5 weeks
|
5 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Teng Kim Tiu, Malaysia Palm Oil Board
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 625.9
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammation
-
University of EdinburghUmeå UniversityCompletedSystemic Inflammation | Respiratory InflammationSweden
-
University of AarhusAarhus University Hospital; University of CopenhagenCompletedSystemic Inflammation | Airway InflammationDenmark
-
Sykehuset TelemarkRikshospitalet University Hospital; Helse Sor-OstCompletedAirway Inflammation | Peripheral Blood Inflammation Markers | Cement Dust ExposureNorway
-
Center for Research and Innovation Viña Concha...Universidad Católica del MauleNot yet recruitingInflammaging | Antioxidant Status, Inflammation | Inflammation Biomarkers | Antioxidant Capabilities | Cardiometabolic Health IndicatorsChile
-
University of NebraskaRecruiting
-
Central Hospital, Nancy, FranceRecruiting
-
Oral Science International Inc.AdvarraNot yet recruiting
-
University of NebraskaCompletedPeriodontal InflammationUnited States
-
University of California, DavisCompleted
-
Università degli Studi di BresciaCompletedVitreous Inflammation
Clinical Trials on Novel Olein
-
Malaysia Palm Oil BoardUnknown
-
Imperial College LondonMalaysia Palm Oil BoardCompletedHealthy VolunteersUnited Kingdom
-
Malaysia Palm Oil BoardCompleted
-
Imperial College LondonMalaysia Palm Oil BoardCompletedLipidaemiaUnited Kingdom
-
Malaysia Palm Oil BoardUniversiti Putra Malaysia; International Medical UniversityCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedIntestinal Bacteria Flora Disturbance | Feeding; Disorder, Nonorganic Origin | Calcium DisorderTurkey
-
King's College LondonCompletedHealthy Men | Raised Fasting Plasma Triacylglycerol ConcentrationsUnited Kingdom
-
Universiti Kebangsaan Malaysia Medical CentreMalaysia Palm Oil Board; Hovid BerhadNot yet recruitingAlcoholic Fatty Liver DiseaseMalaysia
-
Malaysia Palm Oil BoardUniversiti Putra Malaysia; Ministry of Health, MalaysiaCompletedType 2 Diabetes MellitusMalaysia
-
Malaysia Palm Oil BoardInternational Medical University (IMU), Kuala Lumpur,MalaysiaCompleted